<?xml version="1.0" encoding="UTF-8"?>
<p id="Par20">Terpenoids isolated from medicinal plants have attracted attention because many of them exhibit specific 
 <italic>in vitro</italic> antiviral effect against SARS-CoV (Wen et al. 
 <xref ref-type="bibr" rid="CR116">2007</xref>). Triterpenoids inhibit the entry of Ebola, Marburg, HIV, and influenza A viruses with distinct structure-activity relationships (Si et al. 
 <xref ref-type="bibr" rid="CR104">2018</xref>). These natural agents modulate a broad range of virus-host fusion functions via wrapping the heptad repeat 2 domain prevalent in viral envelopes. 
 <italic>Euphorbia neriifolia</italic> L. produces 22 triterpenoids with stronger activity against HCoVs than actinomycin D (Chang et al. 
 <xref ref-type="bibr" rid="CR7">2012</xref>).
</p>
